Vasoactive peptides as biomarkers for the prediction of retinopathy of prematurity

Roland P. Neumann,Roland Gerull,Pascal W. Hasler,Sven Wellmann,Sven M. Schulzke
DOI: https://doi.org/10.1038/s41390-024-03091-w
IF: 3.953
2024-02-25
Pediatric Research
Abstract:Retinopathy of prematurity (ROP) is a major complication in preterm infants. We assessed if plasma levels of midregional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) serve as early markers for subsequent ROP development in preterm infants <32 weeks gestation.
pediatrics
What problem does this paper attempt to address?